<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>FDA Smacks Pravachol for Misleading  Ads</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2003/08/14/FDA-Smacks-Pravachol-for-Misleading--Ads.aspx</link><description>Direct-to-consumer drug advertising has tripled to $2.8 billion worth a year since the FDA loosened restrictions in 1997. Manufacturers spend almost twice that amount on sales visits to doctors to promote their products, and another $2 billion on "educational</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>